• COVID 19 Pandemic
• Material Impact of COVID-19 on FACT - Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• Restart of Caprolactam
• Disclosure under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - CAPEX Projects.
• Performance of FACT during 2021-22
• FACT Achieves All-time High Sales Turnover
• Officer in charge of administering, enforcing and updating the policy of Determination Of Material / Price Sensitive Information And Disclosure Obligations
• Receipt of provisional recovery under Reasonability Guidelines issued by DOF vide FNo:23011/1/2018-MPR dt. 15th November, 2019
• Voluntary consent of FACT for recovery of unreasonable profit under reasonability guidelines